Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol Succinate and Hydrochlorothiazide Combination in Essential Hypertension
NCT00642096Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2003
- Primary completion
- Jul 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in essential hypertension comparing Metoprolol Succinate + Hydrochlorothiazide, Metoprolol Succinate and Hydrochlorothiazide (3 arms). Primary endpoint: Change in trough sitting diastolic blood pressure at 8 weeks. Started Jun 2003; status: completed.
02
Drugs
metoprololhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00642096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642096.